Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-Agent: * |
Title | The Link Between Cancer & Cardiovascular Disease | |
Description | About Button Contact Us Database Home News How to Help Patients Providers Home Patients Providers Need advice in managing cancer immunotherapy cardiotoxic |
Keywords | N/A |
WebSite | cardioonc.org |
Host IP | 198.71.233.107 |
Location | United States |
Site | Rank |
US$1,470
Last updated: 2023-05-03 07:22:05
cardioonc.org has Semrush global rank of 0. cardioonc.org has an estimated worth of US$ 1,470, based on its estimated Ads revenue. cardioonc.org receives approximately 169 unique visitors each day. Its web server is located in United States, with IP address 198.71.233.107. According to SiteAdvisor, cardioonc.org is safe to visit. |
Purchase/Sale Value | US$1,470 |
Daily Ads Revenue | US$1 |
Monthly Ads Revenue | US$40 |
Yearly Ads Revenue | US$488 |
Daily Unique Visitors | 11 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
cardioonc.org. | A | 600 | IP: 198.71.233.107 |
cardioonc.org. | NS | 3600 | NS Record: ns03.domaincontrol.com. |
cardioonc.org. | NS | 3600 | NS Record: ns04.domaincontrol.com. |
cardioonc.org. | MX | 600 | MX Record: 1 mx.netfirms.com. |
cardioonc.org. | TXT | 3600 | TXT Record: o96oc3c4aofq938dgf5ss5ose1 |
About Button Contact Us Database Home News How to Help Patients Providers Home Patients Providers Need advice in managing cancer immunotherapy cardiotoxicity? Request Assistance the link between CANCER and CARDIOVASCULAR CARDIO- VASCULAR DISEASE Patients We are here to help you get answers and find resources. Providers A database of emerging cardio-oncology issues for oncologists, cardiologists and primary care physicians. Require Assistance? Need advice in managing cancer immunotherapy cardiotoxicity? NEWS FDA Public Workshop: Assessment of Cardiovascular Toxicities in Immuno-oncology Trials Posted by Moslehi on January 22, 2018 On Friday, December 1, 2017, the U.S. Food & Drug Administration (FDA) announced a public workshop entitled, “Assessment of Cardiovascular Toxicities in Immuno-oncology Trials”. This workshop provided a forum for discussion of cardiovascular toxicities in immuno-oncology clinical trials. The workshop focused on the identification... Read More Manuscripts |
HTTP/1.1 301 Moved Permanently Age: 0 Content-Security-Policy: upgrade-insecure-requests Content-Type: text/html; charset=iso-8859-1 Date: Mon, 25 Oct 2021 14:40:37 GMT Location: https://cardioonc.org/ Vary: User-Agent, Accept-Encoding X-Backend: local X-Cache: uncached X-Cache-Hit: MISS X-Cacheable: NO:HTTPS Redirect X-Content-Type-Options: nosniff X-Xss-Protection: 1; mode=block HTTP/2 200 server: openresty date: Mon, 25 Oct 2021 14:40:37 GMT content-type: text/html; charset=UTF-8 content-length: 29482 accept-ranges: bytes age: 1658 content-security-policy: upgrade-insecure-requests strict-transport-security: max-age=300 vary: Accept-Encoding, User-Agent x-backend: local x-cache: cached x-cache-hit: HIT x-cacheable: YES:Forced x-content-type-options: nosniff x-xss-protection: 1; mode=block strict-transport-security: max-age=31536000; includeSubDomains |
WHOIS LIMIT EXCEEDED - SEE WWW.PIR.ORG/WHOIS FOR DETAILS |